Related references
Note: Only part of the references are listed.Isothiafludine, a novel non-nucleoside compound, inhibits hepatitis B virus replication through blocking pregenomic RNA encapsidation
Li Yang et al.
ACTA PHARMACOLOGICA SINICA (2014)
Meeting report: 27th International conference on antiviral research, in Raleigh, NC, USA
R. Anthony Vere Hodge
ANTIVIRAL RESEARCH (2014)
Hepatitis B: future curative strategies
Antonio Bertoletti et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2014)
HAPS HEPATITIS B VIRUS (HBV) CAPSID INHIBITORS PREVENT HBC INTERACTION WITH THE VIRAL MINICHROMOSOME AND SELECTED HOST CELL GENES TO INHIBITS TRANSCRIPTION AND AFFECT CCCDNA STABILITY
L. Belloni et al.
DIGESTIVE AND LIVER DISEASE (2014)
Occult Hepatitis B Infection
Teresa Pollicino et al.
JOURNAL OF HEPATOLOGY (2014)
New therapeutic perspectives in HBV: when to stop NAs
Cristina Perez-Cameo et al.
LIVER INTERNATIONAL (2014)
Hepatitis B virus coinfection in human immunodeficiency virus-infected patients: A review
Hsin-Yun Sun et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Then and now: The progress in hepatitis B treatment over the past 20 years
Dina Halegoua-De Marzio et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Combined hexavalent diphtheria-tetanus-acellular pertussis-hepatitis B- inactivated poliovirus-Haemophilus influenzae type b vaccine-Infanrix™ hexa
Vincenzo Baldo et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2014)
New therapeutic vaccination strategies for the treatment of chronic hepatitis B
Jia Liu et al.
VIROLOGICA SINICA (2014)
Clinical impact of occult hepatitis B virus infection in immunosuppressed patients
Evangelista Sagnelli et al.
WORLD JOURNAL OF HEPATOLOGY (2014)
Chronic hepatitis B: Advances in treatment
Teresa Antonia Santantonio et al.
WORLD JOURNAL OF HEPATOLOGY (2014)
Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening
Susan J. M. Hahne et al.
BMC INFECTIOUS DISEASES (2013)
DNA vaccine cocktail expressing genotype A and C HBV surface and consensus core antigens generates robust cytotoxic and antibody responses in mice and Rhesus macaques
N. Obeng-Adjei et al.
CANCER GENE THERAPY (2013)
BASIC AND TRANSLATIONAL-LIVER
Robert E. Lanford et al.
GASTROENTEROLOGY (2013)
Hepatitis B vaccine in celiac disease: Yesterday, today and tomorrow
Giovanna Vitaliti et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Economic analysis of the first 20 years of universal hepatitis B vaccination program in Italy An a posteriori evaluation and forecast of future benefits
Sara Boccalini et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
The potential of 1018 ISS adjuvant in hepatitis B vaccines HEPLISAV™ review
Nelson F. Eng et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Immune Therapeutic Strategies in Chronic Hepatitis B Virus Infection: Virus or Inflammation Control?
Antonio Bertoletti et al.
PLOS PATHOGENS (2013)
Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection
Antonio Bertoletti et al.
GUT (2012)
IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome
Laura Belloni et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
The option of HBIG-free prophylaxis against recurrent HBV
Alyson N. Fox et al.
JOURNAL OF HEPATOLOGY (2012)
EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2012)
Intramuscular vs intradermal route for hepatitis B booster vaccine in celiac children
Salvatore Leonardi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
The worldwide impact of vaccination on the control and protection of viral hepatitis B
Luisa Romano et al.
DIGESTIVE AND LIVER DISEASE (2011)
Entecavir Monotherapy Is Effective in Suppressing Hepatitis B Virus After Liver Transplantation
James Fung et al.
GASTROENTEROLOGY (2011)
Safety and Immunogenicity of 4 Intramuscular Double Doses and 4 Intradermal Low Doses vs Standard Hepatitis B Vaccine Regimen in Adults With HIV-1 A Randomized Controlled Trial
Odile Launay et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Long-term antibody persistence and immune memory to hepatitis B virus in adult celiac patients vaccinated as adolescents
F. Zingone et al.
VACCINE (2011)
Occult hepatitis B virus infection: A complex entity with relevant clinical implications
Juan Ramon Larrubia
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
The natural history of chronic HBV infection and geographical differences
Yun-Fan Liaw et al.
ANTIVIRAL THERAPY (2010)
EMTRICITABINE TENOFOVIR DF COMBINATION plus /- HBIG POST-ORTHOTOPIC LIVER TRANSPLANTATION TO PREVENT HEPATITIS B RECURRENCE IN PATIENTS WITH NORMAL TO MODERATE RENAL IMPAIRMENT: INTERIM RESULTS
L. Teperman et al.
JOURNAL OF HEPATOLOGY (2010)
High rates of serological response to a modified hepatitis B vaccination schedule in HIV-infected adults subjects
D. V. Potsch et al.
VACCINE (2010)
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
Yun-Fan Liaw et al.
HEPATOLOGY INTERNATIONAL (2008)
Independent clinical predictors of impaired response to hepatitis B vaccination in HIV-infected persons
H. Nina Kim et al.
INTERNATIONAL JOURNAL OF STD & AIDS (2008)
Pathogenic mechanisms of B-lymphocyte dysfunction in HIV disease
Susan Moir et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2008)
Statements from the Taormina expert meeting on occult hepatitis B virus infection
Giovanni Raimondo et al.
JOURNAL OF HEPATOLOGY (2008)
Universal hepatitis B vaccination
Marcello Piazza
LANCET INFECTIOUS DISEASES (2008)
Immunological response to hepatitis B vaccination in patients with AIDS and virological response to highly active antiretroviral therapy
Leilani Paitoonpong et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2008)
Hepatitis B virus infection and transfusion medicine: science and the occult
F. Blaine Hollinger
TRANSFUSION (2008)
Review: Hepatitis B immune globulin for prevention of hepatitis B infection
J. N. Zuckerman
JOURNAL OF MEDICAL VIROLOGY (2007)
Should hepatitis B vaccination be introduced into childhood immunisation programmes in northern Europe?
Jane Zuckerman et al.
LANCET INFECTIOUS DISEASES (2007)
Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy
JJY Sung et al.
GASTROENTEROLOGY (2005)
Randomized trial of recombinant hepatitis B vaccine in HIV-infected adult patients comparing a standard dose to a double dose
MO Fonseca et al.
VACCINE (2005)
HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination
CB Wang et al.
HEPATOLOGY (2004)
Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan
HY Hsu et al.
GUT (2004)
Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy
B Werle-Lapostolle et al.
GASTROENTEROLOGY (2004)
Impact of universal vaccination programmes on the epidemiology of hepatitis B: 10 years of experience in Italy
P Bonanni et al.
VACCINE (2003)
Enumeration of hepatitis B surface antigen-specific B lymphocytes in responder and non-responder normal individuals vaccinated with recombinant hepatitis B surface antigen
MA Shokrgozar et al.
IMMUNOLOGY (2001)
Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen
MP Cooreman et al.
JOURNAL OF BIOMEDICAL SCIENCE (2001)
Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects on HIV-1 viral load
D Rey et al.
VACCINE (2000)
Share Paper
